EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier

Patrícia Alencar Alves, Luana Cristina Camargo iD, Gabriel Mendonça de Souza, Márcia Renata Mortari iD, Mauricio Homem-de-Mello iD

Pharmaceuticals · 06.02.2025 · 18 (2) · 217

DOI: 10.3390/ph18020217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.02.2025. Verfasst von Patrícia Alencar Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: In Silico Toxicology Laboratory (inSiliTox), Department of Pharmacy, Health Sciences School, University of Brasilia, Brasilia 71910-900, Brazil. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Research Support of the Federal District, National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery and development of new pharmaceutical drugs is a costly, time-consuming, and highly manual process, with significant challenges in ensuring drug bioavailability at target sites. Computational techniques are highly employed in drug design, particularly to predict the pharmacokinetic properties of molecules. One major kinetic challenge in central nervous system drug development is the permeation through the blood–brain barrier (BBB). Several different computational techniques are used to evaluate both BBB permeability and target delivery. Methods such as quantitative structure–activity relationships, machine learning models, molecular dynamics simulations, end-point free energy calculations, or transporter models have pros and cons for drug development, all contributing to a better understanding of a specific characteristic. Additionally, the design (assisted or not by computers) of prodrug and nanoparticle-based drug delivery systems can enhance BBB permeability by leveraging enzymatic activation and transporter-mediated uptake. Neuroactive peptide computational development is also a relevant field in drug design, since biopharmaceuticals are on the edge of drug discovery. By integrating these computational and formulation-based strategies, researchers can enhance the rational design of BBB-permeable drugs while minimizing off-target effects. This review is valuable for understanding BBB selectivity principles and the latest in silico and nanotechnological approaches for improving CNS drug delivery.

Schlagwörter

Stichwörter der Autor:innen

CNS-targeted nanoparticlesblood–brain barriercentral nervous system drugsend-point free energyin silico drug designmachine learningmembrane transportersmolecular dockingmolecular dynamicsneuroactive peptidesprodrug designquantitative structure–activity relationship

Autor:innen und Institutionen

  • In Silico Toxicology Laboratory (inSiliTox), Department of Pharmacy, Health Sciences School, University of Brasilia, Brasilia 71910-900, Brazil.
  • Psychobiology Laboratory, Department of Basic Psychological Processes, Institute of Psychology University of Brasilia, Brasilia 71910-900, Brazil.
  • Neuropharmacology Laboratory, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia 71910-900, Brazil.

ORCID-Profile: Luana Cristina Camargo, Márcia Renata Mortari, Mauricio Homem-de-Mello

Förderung

  • Foundation for Research Support of the Federal District
  • National Council for Scientific and Technological Development
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • FAPDF
  • CNPq
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)
  • University of Brasilia

Zitieren

APA

Alves, P. A., Camargo, L. C., Souza, G. M., Mortari, M. R., & Homem-de-Mello, M. (2025). Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier. Pharmaceuticals, 18(2), 217. https://doi.org/10.3390/ph18020217

Vancouver

Alves PA, Camargo LC, Souza GM, Mortari MR, Homem-de-Mello M. Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier. Pharmaceuticals. 2025;18(2):217. doi:10.3390/ph18020217

BibTeX
@article{Alves2025,
  author = {Alves, Patrícia Alencar and Camargo, Luana Cristina and Souza, Gabriel Mendonça de and Mortari, Márcia Renata and Homem-de-Mello, Mauricio},
  title = {Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {2},
  pages = {217},
  doi = {10.3390/ph18020217}
}
Kostenlos starten →